Rapid rise in paediatric COVID-19 hospitalisations during the early stages of the Omicron wave, Tshwane District, South Africa

Abstract

Background South Africa reported a notable increase in COVID-19 cases from mid-November 2021 onwards, starting in Tshwane District, linked to rapid community spread of the Omicron variant. This coincided with a rapid rise in paediatric COVID-19-associated hospitalisations. Methods We synthesized data from five sources to describe the impact of Omicron on clinical manifestations and outcomes of hospitalized children (≤19 years) with positive SARS-CoV-2 tests in Tshwane District from 31 October to 11 December 2021, including: 1) COVID-19 line lists; 2) collated SARS-CoV-2 testing data; 3) SARS-CoV-2 genomic sequencing data; 4) COVID-19 hospitalisation surveillance; and 5) clinical data of public sector paediatric (≤13 years) COVID-19 hospitalisations. Findings During the six-week period 6,287 paediatric (≤19 years) COVID-19 cases were recorded in Tshwane District, of these 462 (7.2%) were hospitalized in 42 hospitals (18% of overall admissions). The number of paediatric cases was higher than in the prior 3 waves, uncharacteristically preceding adult hospitalisations. Of the 75 viral specimens sequenced from the district, 99% were Omicron. Detailed clinical information obtained from 139 of 183 (76%) admitted children (≤13 years; including all public sector hospitalisations) indicated that young children (0-4 years) were most affected (62%). Symptoms included fever (47%), cough (40%), vomiting (24%), difficulty breathing (23%), diarrhoea (20%) and convulsions (20%). Length of hospital stay was short (mean 3.2 days), and in 44% COVID-19 was the primary diagnosis. Most children received standard ward care (92%), with 31 (25%) receiving oxygen therapy. Seven children (6%) were ventilated; four children died, all related to complex underlying co-pathologies. All children and majority of parents for whom data were available were unvaccinated. Interpretation Rapid increases in paediatric COVID-19 cases and hospitalisations mirror high community transmission of SARS-CoV-2 (Omicron variant) in Tshwane District, South Africa. Continued monitoring is needed to understand the long-term impact of the Omicron variant on children.

COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research

“…The defective protective antibody response in patients with HM further calls for research to examine, in these patients, the possibility of enhanced strategies for immunization adjuvants to boost antibody response as well consideration of passive immune protection, using either convalescent serum, monoclonal antibodies [ 37 ] or prophylactic use of intravenous immunoglobulin (IVIG), which has recently been demonstrated to contain COVID-19 protective antibodies [ 38 ] and recently suggested as a protective strategy for immunosuppressed patients receiving CAR-T Therapy [ 39 ]. SARS-CoV-2 infections and hospitalizations are rising in the US after the emergence of the Omicron variant in December 2021 [ 40 ]. The Omicron variant is more transmissible than earlier variants.…”

COVID infection severity in children under 5 years old before and after Omicron emergence in the US

“…Pediatric SARS-CoV-2 infections and hospitalizations are rising in the US and other countries after the emergence of Omicron variant 1 . This is especially concerning for children under 5 years old since they are not eligible for COVID-19 vaccines and their low rates of previous SARS-CoV-2 infection also limits their pre-existing immunity 2 .…”

COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the general population of the capital city Tunis

“…Previous longitudinal studies have found increased SARS-CoV-2 seropositivity among children along with the overall transmission of COVID-19 [41][42][43]. In addition, with the emergence of the Omicron variant, a rise in COVID-19 pediatric cases was noted [44]. This raises the concern of the potential in uence of variants emergence on the transmission of SARS-CoV-2 among children.…”